Wright Medical Group, Inc. Highlights Recent Innovations at the American Academy of Orthopaedic Surgeons (AAOS) 2015 Annual Meeting

MEMPHIS, Tenn., March 24, 2015 (GLOBE NEWSWIRE) -- Wright Medical Group, Inc. (Nasdaq:WMGI) today announced that it will highlight recent innovations at the American Academy of Orthopaedic Surgeons (AAOS) 2015 Annual Meeting taking place at the Venetian/Sands EXPO in Las Vegas, Nevada from March 24-28, 2015.

Wright will feature its full range of foot and ankle reconstructive solutions at exhibit booth #3425, including the following products and recent innovations:

  • INFINITY® Total Ankle Replacement (TAR) System – The lower profile design and straightforward surgical approach of the INFINITY® TAR system can expand access to less complicated primary cases and is an important addition to the continuum of care for end-stage ankle arthritis patients.
  • INBONE® II TAR System – Several product line extensions for the INBONE® II TAR system will be featured, including the availability of a smaller size talar dome to address patients with small anatomy who would benefit from a smaller talar dome option as well as a revision poly insert and uncoated tibia stems to provide surgeons with more options.
  • PROPHECY® Pre-Operative Navigation Alignment Guides – Designed for use with the Company's INFINITY® and INBONE® TAR Systems, the PROPHECY® Pre-Operative Navigation Alignment Technology utilizes computed tomography (CT) scans to create patient-specific ankle alignment guides that facilitate the surgeons' ability to precisely size, place and align the INFINITY® and INBONE® TAR components during surgery.
  • ORTHOLOC® 3Di Flatfoot Plates – Designed to increase the speed and accuracy of complex flatfoot procedures, the ORTHOLOC® 3Di flatfoot system is a comprehensive flatfoot osteotomy solution that features innovative 3Di medial displacement calcaneal osteotomy plating technology.

Wright also announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the SALVATION™ External Fixation System. The SALVATION™ External Fixation System is an integral part of Wright's SALVATION™ Limb Salvage product portfolio, which includes the SALVATION™ Beaming System and the SALVATION™ 3Di Plating System. Together, this comprehensive portfolio of products is designed to address fractures, nonunions and complex foot and ankle deformities and is the first complete portfolio of products to be specifically indicated for use to treat neuropathic osteoarthropathy (commonly referred to as Charcot foot), a deformity (most commonly mid-foot collapse) that results from nerve damage in the foot or ankle. Wright expects to initiate limited physician testing of the SALVATION™ External Fixation System to collect market assessment data in the second quarter of 2015.

Robert Palmisano, president and chief executive officer, commented, "We have continued to expand our broad product portfolio to further extend our leadership position in foot and ankle. The INFINITY ankle's lower profile design and straightforward surgical approach expands our access to less complicated primary cases and continues to be an important catalyst in the ongoing market conversion from fusion procedures to total ankle replacement. In addition, we have a unique future opportunity to address advanced reconstructive, limb salvage, and Charcot cases with our SALVATION product portfolio. Despite the large and growing population at high-risk of peripheral neuropathies, the Charcot market remains underserved in terms of a comprehensive solution. We are looking forward to collecting initial physician testing and market assessment data for our SALVATION product portfolio in preparation for a future product launch." 

More information on Wright Medical's foot and ankle products can be found at www.wmt.com/footandankle/. Wright is the exclusive sponsor of WebMD's patient education section on total ankle replacement, which can be accessed at www.webmd.com/osteoarthritis/ankle-replacement-15.

About Wright Medical

Wright Medical Group, Inc. is a specialty orthopaedic company that provides extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients' lifestyles. The company is the recognized leader of surgical solutions for the foot and ankle market, one of the fastest growing segments in medical technology, and markets its products in over 60 countries worldwide. For more information about Wright Medical, visit www.wmt.com.

Cautionary Note Regarding Forward-Looking Statements  

This press release includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," "forecast," "goal," "project," and other words of similar meaning. Forward-looking statements in this press release include, but are not limited to, statements about the potential for market acceptance and clinical performance of our products. Each forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, the risk that competitive products achieve greater clinical success or market acceptance than our products, or that our products, for whatever reason, are less successful or clinically effective than presently anticipated, and the risks identified under the heading "Risk Factors" in Wright's Annual Report on Form 10-K, filed with the SEC on February 26, 2015, as supplemented by our subsequent Quarterly Reports on Form 10-Q and other information filed with the SEC. Investors should not place considerable reliance on the forward-looking statements contained in this press release. You are encouraged to read Wright's filings with the SEC, available at www.sec.gov, for a discussion of these and other risks and uncertainties. The forward-looking statements in this press release speak only as of the date of this release, and Wright undertakes no obligation to update or revise any of these statements. Wright's business is subject to substantial risks and uncertainties, including those referenced above. Investors, potential investors, and others should give careful consideration to these risks and uncertainties.



Contact Data